Diben 500mL EasyBag

Product categories

Product tags

Latest Products

Filter Products

Product categories

Product tags


15 per pack

Package Option


Why Choose Noble Healthcare?

  • Real Support – Speak to us in person – freecall-1800 780 699
  • Australian owned 100%
  • If you are not 100% satisfied with your product we will refund you in full.
  • Free returns of unused disposable continence products up to 6 months
  • Registered NDIS Provider

Possible stock delays
Please email or ring us to confirm if urgent

Lowest price guaranteed for disposable nappies, pants and pads *

Please provide a written quote for an equivalent product and we will match it
Send to – sales@noblehealthcare.com.au

1 kcal/ml  22.5 g protein

For the dietary management of patients with or at risk of malnutrition with impaired glucose metabolism such as in impaired glucose tolerance, stress-induced hyperglycaemia, diabetes mellitus.
Available in 500 ml EasyBag.

  • Energy: 1.05 kcal/mL - 525 kcal per 500mL bag
  • Protein: 22.5g per 500mL bag
  • With fibre
  • With clinical evidence from multicentre trial demonstrating positive long-term effects on nutritional parameters1,2 relevant for the target group
  • Modified carbohydrate profile: With low glycaemic index for improved glycaemic control3,4
  • Adapted fat profile:
    High in MUFA contributes to improve glycaemic control5-7 and insulin sensitivity8-10
    With fish oil according to recommendation for cardiovascular diseases* as XY% of diabetic patients have additional cardiovascular problems**
  • Increased chromium helps to improve insulin sensitivity14


1)  Pohl M, Mayr P, Mertl-Roetzer M, et al. Glycaemic control in type II diabetic tube-fed patients with a new enteral formula low in carbohydrates and high in monounsaturated fatty acids: a randomised controlled trial. Eur J Clin Nutr. 2005;59(11):1221-1232.
2) Pohl M, Mayr P, Mertl-Roetzer M, et al. Glycemic control in patients with type 2 diabetes mellitus with a disease-specific enteral formula: stage II of a randomized, controlled multicenter trial. JPEN. 2009;33(1):37–49.
3) Thomas DE & Elliott EJ. The use of low-glycaemic index diets in diabetes control. Br J Nutr. 2010;104(6):797-802.
4)  Barazzoni R, Deutz NE, Biolo G, et al. Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert group. Clin. Nutr. 2017;36(2): 355-363.
5) Pohl M, Mayr P, Mertl-Roetzer M, et al. Glycemic control in patients with type 2 diabetes mellitus with a disease-specific enteral formula: stage II of a randomized, controlled multicenter trial. JPEN. 2009;33(1):37–49.
6) Lochs H, Allison SP, Meier R, et al. Introductory to the ESPEN Guidelines on Enteral nutrition: terminology, definitions and general topics. Clin Nutr. 2006;25(2):180–186.
7) Qian F, Korat AA, Malik V,et al. Metabolic effects of monounsaturated fatty acid–enriched diets compared with carbohydrate or polyunsaturated fatty acid–enriched diets in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care. 2016;39(8):1448–1457.
8) Paniagua JA, De La Sacristana AG, Romero I, et al. Monounsaturated fat–rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbohydrate-rich diet in insulin-resistant subjects. Diabetes Care. 2007;30(7):1717-1723.
9)  Brehm BJ, Lattin BL, Summer SS, et al. One-year comparison of a high–monounsaturated fat diet with a high-carbohydrate diet in type 2 diabetes.  Diabetes Care. 2009;32(2):215–220.
10) Gadgil MD, Appel LJ, Yeung E, et al. The Effects of Carbohydrate, Unsaturated Fat, and Protein Intake on Measures of Insulin Sensitivity. Diabetes Care. 2013;36(5):1132-1137.
11) Kris-Etherton PM, Grieger JA, Etherton TD. Dietary reference intakes for DHA and EPA. Prostaglandins,  Leukotrienes and Essential Fatty Acids. 2009;81(2-3):99-104.
12) International Society for the Study of Fatty Acids and Lipids (ISSFAL): Recommendations for Dietary Intake of Polyunsaturated Fatty Acids in Healthy Adults. Report June 2004.
13) Lee JH, O'keefe JH, Lavie CJ, et al. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc. 2008;83(3):324-332
14) Suksomboon N, Poolsup N, Yuwanakorn A. Systematic review and meta‐analysis of the efficacy and safety of chromium supplementation in diabetes. J. Clin Pharm Ther 2014;39(3):292-306.

ALLERGENS: This product contains milk, soy and and fish oil.

Fact Sheet

15 per pack

Can't find what you were looking for?

We can source and supply any product/brand
Click here to send us what your product you require and we will send price
If you can also attach an image if you have one.

Or ring us on 1800 780 699

Molicare, Tena
Catheters, Leg Bags,
Wound Dressings
All Medical

“We make it easy to order”